文献速递脑血管病外科

荧光素钠视频血管造影作为脑动静脉畸形切除术的辅助手段

Sodium Fluorescein Videoangiography as an Adjunct to Resection of Cerebral Arteriovenous Malformations.
PubMed 文献 · World Neurosurg · 2018-06-12

前瞻性招募12例脑动静脉畸形患者,在切除各阶段行荧光素钠视频血管造影(FL-VAG),记录供血动脉转运时间(TTa)、初始引流静脉转运时间(初始TTv)和最终引流静脉转运时间(最终TTv)。当最终TTv明显慢于初始TTv时,推测畸形团已充分去血管化并可安全切除。无与FL使用相关的死亡或并发症。

要点

  • FL-VAG可区分引流血管的正常与异常血流。
  • 最终TTv较初始TTv明显减慢提示畸形团可安全切除。
  • 荧光素钠最佳剂量为75 mg团注后注射20 mL生理盐水。

核心结论

  • FL-VAG可区分引流血管的正常与异常血流,可能帮助术者判断畸形团何时可安全切除。
  • 这是首项前瞻性评估该技术的研究,并提出了脑动静脉畸形手术的理想剂量,与肿瘤病例所用剂量不同。

研究设计与样本

  • 前瞻性招募12例脑动静脉畸形患者,以FL-VAG作为病灶切除的辅助技术。
  • 分析切除不同阶段荧光素在供血动脉(TTa)和引流静脉(TTv)中的转运时间。
  • 记录3个荧光素转运时间值:TTa、初始TTv、最终TTv。

主要发现

  • 无与FL使用相关的死亡或并发症。
  • 多数病例中,供血动脉和引流静脉的TT值有助于更容易地区分二者。
  • 切除晚期,FL-VAG评估显示TTv增加(静脉血变慢或消失),提示多数供血动脉已闭塞,表明为畸形团切除的适当时机。
  • 荧光素钠最佳剂量为75 mg团注后注射20 mL生理盐水。

关键数值与推荐

  • 最终TTv明显慢于初始TTv时,推测畸形团已充分去血管化并可安全切除。
  • 荧光素钠最佳剂量为75 mg团注后注射20 mL生理盐水。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize dynamic changes of arteriovenous malformation using a microscope-integrated technique at the moment of performing intraoperative fluorescein videoangiography (FL-VAG) at each of the resection phases. METHODS: We prospectively recruited 12 patients with arteriovenous malformations and used FL-VAG as an ancillary technique for resection of the lesion. We analyzed transit time (TT) of FL in arterial feeders (arterial transit time [TTa]) and draining veins (venous transit time [TTv]) during the different stages of resection. To achieve this, we recorded 3 values of TT of FL (TTa, initial TTv, final TTv); when final TTv was markedly slower than initial TTv, we hypothesized that the nidus was devascularized enough and could be safely removed. RESULTS: No mortality or morbidity was related to use of FL. In most cases, TT values of arterial feeders and draining veins allowed an easier distinction between them. At advanced stages of resection, FL-VAG assessed increase in TTv (venous blood slower or absent), suggesting that most feeding arteries had been obliterated, indicating the appropriate moment for nidus removal. Optimal dose of FL was a 75-mg bolus followed by injection of 20 mL of saline solution. CONCLUSIONS: FL-VAG allows a distinction of normal from abnormal flow in draining vessels and might help the surgeon to decide when the nidus can be safely removed. This is the first study prospectively evaluating this technique, and it proposes an ideal dose for brain arteriovenous malformation surgery, in contrast to doses used in tumor cases.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Serrano-Rubio A, Ruiz-Treviño AS, Orenday-Barraza JM, et al. Sodium Fluorescein Videoangiography as an Adjunct to Resection of Cerebral Arteriovenous Malformations. World Neurosurg. 2018. PMID: 29906575. doi:10.1016/j.wneu.2018.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。